InnovaQor, Inc. financial data

Symbol
INQR on OTC
Location
400 South Australian Avenue, Suite 800, West Palm Beach, FL
State of incorporation
NV
Fiscal year end
December 31
Former names
VisualMED Clinical Solutions Corp. (to 1/20/2011), ANCONA MINING CORP (to 1/6/2005)
Latest financial report
10-Q - Q3 2023 - Nov 20, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.21 %
Debt-to-equity -100 %
Return On Equity 14.8 %
Return On Assets -3.43K %
Operating Margin -295 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 245M shares
Common Stock, Shares, Outstanding 245M shares +4.26%
Common Stock, Value, Issued 24.5K USD +4.26%
Weighted Average Number of Shares Outstanding, Basic 245M shares +4.26%
Weighted Average Number of Shares Outstanding, Diluted 245M shares +4.26%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 102K USD +205%
Revenue from Contract with Customer, Excluding Assessed Tax 594K USD +94.6%
General and Administrative Expense 1.83M USD +13.4%
Operating Income (Loss) -1.75M USD -20.9%
Nonoperating Income (Expense) -372K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.12M USD -1.74%
Net Income (Loss) Attributable to Parent -2.12M USD -1.74%
Earnings Per Share, Basic -0.01 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.7K USD +333%
Accounts Receivable, after Allowance for Credit Loss, Current 32.6K USD -42.4%
Assets, Current 47.5K USD -20.4%
Assets 47.5K USD -20.4%
Accounts Payable, Current 1.53M USD +27.1%
Accrued Liabilities, Current 1.58M USD +8.62%
Liabilities, Current 5.77M USD +50%
Liabilities 15.2M USD +15.5%
Retained Earnings (Accumulated Deficit) -21.1M USD -11.2%
Stockholders' Equity Attributable to Parent -15.1M USD -15.6%
Liabilities and Equity 47.5K USD -20.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -316K USD -50.3%
Net Cash Provided by (Used in) Financing Activities 314K USD +48.6%
Common Stock, Shares Authorized 2B shares +515%
Common Stock, Shares, Issued 245M shares +4.26%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.22K USD -323%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.53K USD -52%
Property, Plant and Equipment, Gross 1.8M USD 0%
Additional Paid in Capital 5.91M USD +0.84%
Interest Expense -7.37K USD -116%